Precigen
Germantown · Founded 1998
About Precigen
Precigen is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Company Facts
- Founded: 1998
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $809.8M
- Funding stage: IPO
- Last round: Post-IPO Debt (Sep 2025)
- Ticker: nasdaq:PGEN
- Website: precigen.com
- Phone: 15409610734
Industries & Categories
Biotechnology, Life Science, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/precigen-48832 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.